Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials.

Ji Xiong,Shujie Lai,Piyun Zhang,Qing Li,Yanling Wei,Yang Yang,Tao Wang,Lei Liu,Xiangyu Ma,Dongfeng Chen

Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials.

2014

Ji Xiong
Shujie Lai
Piyun Zhang
Qing Li
Yanling Wei
Yang Yang
Tao Wang
Lei Liu
Xiangyu Ma
Dongfeng Chen

Abbreviations: ESD = endoscopic submucosal dissection, PPI = proton pump inhibitor, S1 = scarring stage 1. Drs DC and XM contributed equally to the work. The authors have no funding and conflicts of interest to disclose.

Keywords:

Diabetes mellitus
Rebamipide
Randomized controlled trial
Gastroenterology
Meta-analysis
Anti-ulcer Agent
Medicine
Adenoma
Proton-pump inhibitor
Internal medicine
Endoscopic submucosal dissection
Combination therapy
Odds ratio
Clinical endpoint

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations